The shrine of knowledge.


Bellerophon is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Bellerophon books and related discussion.

Suggested News Resources

Stock Target & Update on Bellerophon Therapeutics Inc (NASDAQ:BLPH)
Bellerophon Therapeutics Inc (NASDAQ:BLPH) shares traded N/A during the most recent session. Wall Street analysts covering the stock are projecting that the stock will reach $12.00 within the next 52-weeks.
Bellerophon Therapeutics Inc (NASDAQ:BLPH) Street Rating in Focus
There are 4 equity research firms tracked by Zacks that cover shares of Bellerophon Therapeutics Inc (NASDAQ:BLPH). The sell-side analysts offer Buy,Sell or Hold recommendations on the stock. Zacks translates the recommendations into an average ...
Average Rating Update on Bellerophon Therapeutics Inc (NASDAQ:BLPH)
Wall Street analysts have an average broker recommendation of 1 on Bellerophon Therapeutics Inc (NASDAQ:BLPH) shares. The rating is determined by taking the average of all analyst recommendations taken into consideration by Zacks Research.
Bellerophon Therapeutics Incorporated (NASDAQ:BLPH) Shorted Shares Increased
The stock of Bellerophon Therapeutics Incorporated (NASDAQ:BLPH) registered an increase of 103.16% in short interest. BLPH's total short interest was 103,000 shares in March as published by FINRA.
Bellerophon Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule
WARREN, N.J., March 02, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc.

Great care has been taken to prepare the information on this page. Elements of the content come from factual and lexical knowledge databases, library and third-party sources. We appreciate your suggestions and comments on further improvements of the site.

Discussion Forum
Orkut History
Place for your opinion